Schrödinger is abandoning its…
Schrödinger is abandoning its CDC7 inhibitor after the therapy was [...]
A patient has died from kidney…
A patient has died from kidney injury in a trial [...]
Sarepta Therapeutics is selling…
Sarepta Therapeutics is selling off Arrowhead Pharmaceuticals shares to stretch [...]
Generic versions of CSL’s iron…
Generic versions of CSL’s iron replacement therapy Venofer have arrived [...]
Vedanta Biosciences’ dreams of…
Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory [...]
The National Advertising Division…
The National Advertising Division has sided with Genomic Health in [...]
Vor Bio’s big bet on RemeGen’s…
Vor Bio’s big bet on RemeGen’s autoimmune asset telitacicept appears [...]
Hatteras Venture Partners has…
Hatteras Venture Partners has secured over $200 million across a [...]
Texas Attorney General Ken Paxton…
Texas Attorney General Ken Paxton and Health Choice Alliance are [...]
More bad news has come down for…
More bad news has come down for Biohaven’s small molecule [...]